GH/IGF-I axis in anorexia nervosa

Eating and Weight Disorders

Volumn 7, Issue 2, 2002, Pages 94-105

  Gianotti, L ^a   Lanfranco, F ^a   Ramunni, J ^a   Destefanis, S ^a   Ghigo, E ^a   Arvat, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Anorexia nervosa; GH; GHBP; GHRH; IGF I; IGFBPs; Nutrition; Somatostatin

Indexed keywords

AMINO ACID; GLUCOSE; GONADORELIN; GROWTH HORMONE; INSULIN; LIPID; PROTIRELIN; SOMATOMEDIN C; SOMATOMEDIN;

ANOREXIA NERVOSA; GLUCOSE TOLERANCE TEST; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CIRRHOSIS; MALABSORPTION; MALNUTRITION; MOLECULAR PATHOLOGY; NONHUMAN; REVIEW; METABOLISM; NEUROSECRETION; PATHOPHYSIOLOGY; SECRETION;

ANOREXIA NERVOSA; GROWTH HORMONE; HUMANS; MALNUTRITION; NEUROSECRETORY SYSTEMS; SOMATOMEDINS; SOMATOTROPHS;

EID: 0043101922     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03354435     Document Type: Review

References (124)

1. Furlanetto R.W.: Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Horm. Res., 33 (suppl. 4), 25-30, 1990.
2. Casanueva F.F.: Physiology of growth hormone secretion and action. Endocrinol. Metab. Clin. North Am., 21, 483, 1992.
3. Müller E.E, Nisticò G.: Neurotransmitter regulation of the anterior pituitary. In: Muller E.E., Nisticö G. (Eds.), Brain messengers and the pituitary. San Diego, Acadaemic Press, 1989, pp. 404-537.
4. Ghigo E.: Neurotransmitter control of growth hormone secretion. In: De la Cruz L.F. (Ed.), Regulation of growth hormone and somatic growth. Amsterdam, Elsevier Science Publishers, 1992, pp. 103-136.
5. Hartman M.L., Veldhuis J.D., Thorner M.O.: Normal control of growth hormone secretion. Horm. Res. 40, 37-47, 1993.
6. Tannenbaum G.S.: Genesis of episodic growth hormone secretion. J. Pediatr. Endocrinol. Metab., 6, 273-282, 1993.
7. Kojima M., Hosada H., Data Y., Nakazato M., Matzuo H., Kankawa K.: Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature, 402, 656-660, 1999.
8. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F., Deghenghi R., Camanni F., Ghigo E.: Endocrine activities of Ghrelin, a natural growth hormone secreta-gogue (GHS), in humans: comparison and interactions with Hexarelin, a non natural peptydil GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86, 1169-1174, 2001.
9. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M.: Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432, 1994.
10. Bauman G., Shaw M.A., Amburn K.: Circulating growth hormone binding proteins. J. Endocrinol. Invest., 17, 67-81, 1994.
11. Postel-Vinay M.C., Saab C, Gourmelen M.: Nutritional status and growth hormone-binding proteins. Horm. Res. 44, 177-181, 1995.
12. Jones J., Clemmons D.R.: Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16, 3-34, 1995.
13. Zapf J.: Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol., 132, 645-654, 1995.
14. Davidson M.B.: Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev., 8, 115-131, 1987.
15. Wabitsch M., Hauner H., Heinze E., Teller W.: In vitro effects of growth hormone in adipose tissue. Acta Paediatr., 406, 48-53, 1994.
16. De Feo P.P.: Hormonal regulation of human protein metabolism. Eur. J. Endocrinol., 135, 7-18, 1996.
17. Florini J.R., Ewton D.Z., Coolican S.A.: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev., 17, 481-517, 1996.
18. Iranmanesh A., Lizzaralde G., Veldhuis J.D.: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab., 73, 1081-1088, 1991.
19. Thissen J.P., Ketesleger J.M., Underwood L.E.: Nutritional regulation of insulin-like-growth-factors. Endocr. Rev., 15, 80-85, 1994.
20. Ghigo E., Arvat E., Gianotti L., Maccario M., Camanni F.: The regulation of growth hormone secretion. In: Jenkins R.C., Ross R.J.M. (Eds.), The endocrine response to acute illness. Front. Horm. Res. Basel, Karger, 1999, vol. 24, pp. 152-175.
21. Argenté J., Caballo N., Barrios V., Munoz M.T., Pozo J., Chowen J.A., Morande G., Hernandez M.: Multiple endocrine abnormalities of the growth hormone and insulinlike growth factor axis in patients with anorexia nervosa: effect of short and long-term weight recuperation. J. Clin. Endocrinol. Metab., 82, 2084-2092, 1997.
22. Stoving R.K., Veldhuis J.D., Flyybjerg A., Vinten J., Hangaard J., Koldkjaer O.G., Kristiansen J., Hagen K.: Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J. Clin. Endocrinol. Metab., 81, 2056-2063, 1999.
23. Landon J., Greenwood F.C., Stamp T.C.B., Wynn V.: The plasma sugar, free fatty acid, Cortisol and growth hormone response to insulin, and comparison of this procedure with other tests of pituitary and adrenal function in patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J. Clin. Invest., 45, 437-449, 1966.
24. Mecklenburg R.S., Loriaux L., Thompson R.H., Andersen A.E., Lipsett M.B.: Hypothalamic dysfunction in patients with anorexia nervosa. Medicine, 53, 147-159, 1974.
25. Brown G.M., Garfinkel P.E., Jeuniewic N., Moldofsky H., Stancer H.C.: Endocrine profiles in anorexia nervosa. In: Vigersky R. (Ed.), Anorexia nervosa. New York, Raven Press, 1977, pp. 123-135.
26. Halmi K.A.: Anorexia nervosa: recent investigation. Annu. Rev. Med., 29, 137-148, 1978.
27. Dieguez C, Page M.D., Scanion M.F.: Growth regulation and its alteration in disease states. Clin. Endocrinol., 28, 109-143, 1988.
28. Donaghy A.J., Baxter R.C.: Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. In: Ross R.J.M., Savage M.O. (Eds.), Bailliere's Clin. Endocrinol. Metab., Growth hormone resistance. W.B. Saunders, London, 10, 421-447, 1996.
29. Argenté J., Munoz M.T., Pozo J., Barrios V., Buno M., Chowen J.A., Hernandez M.: Growth hormone resistance in anorexia nervosa as a model of malnutrition. J. Endocrinol. Invest, 21, 24-28, 1998.
30. Counts D.R., Gwirtsman H., Carlsson L.M.S., Lesem M., Cutler G.B.: The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 75, 762-767, 1992.
31. Bentham J., Rodriguez-Arnao J., Ross R.J.M.: Acquired growth hormone resistance in patients with hypercatabolism. Horm. Res., 40, 87-91, 1993.
32. Ross R.J.M., Chew S.L.: Acquired growth hormone resistance. Eur. J. Endocrinol., 132, 655-660, 1995.
33. Veldhuis J.D., Carlson M.L., Johnson M.L.: The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc. Natl. Acad. Sci. USA, 84, 7686-7690, 1987.
34. Scacchi M., Pincelli A.I., Caumo A., Tomasi P., Delitalia G., Baldi G., Cavagnini F.: Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 82, 3225-3229, 1997.
35. Pirke K.M., Ficher M.M., Pahl J.: Noradrenaline, triiodothyronine, growth hormone and prolactin during weight gain in anorexia nervosa. Int. J. Eat. Dis., 4, 499-502, 1985.
36. Vigersky R.A., Loriaux D.L.: Anorexia nervosa as a model of hypothalamic dysfunction. In: Vigersky R.A. (Ed.), Anorexia nervosa. New York, Raven Press, 1977, pp. 109-121.
37. Nussbaum M.P.: Anorexia nervosa. In: McArney M.D. (Ed.), Textbook of adolescent medicine. Philadelphia, Saunders W.B., 1992, p. 536.
38. Aro A., Lamberg B.A., Pelkonen R.: Hypothalamic endocrine dysfunction in anorexia nervosa. Acta Endocrinol., 5, 673-678, 1977.
39. Gianotti L., Pincelli A.I., Scacchi M., Rolla M., Bellitti D., Arvat E., Lanfranco F., Torsello A., Ghigo E., Cavagnini F., Müller E.E.: Effects of recombinant human insulinlike growth factor I administration on spontaneous and growth hormone (GH) - releasing hormone stimulated GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 85, 2805-2809, 2000.
40. Shibasaki T., Hotta M., Masuda A. et al.: Plasma GH response to GHRH and insulin hypoglycemia in man. J. Clin. Endocrinol. Metab., 60, 1265-1267, 1985.
41. Roth J., Glick S.M., Yalow R.S., Berson S.A.: Secretion of human growth hormone: Physiologic and experimental modification. Metabolism, 58, 577-581, 1963.
42. Schreiber W., Schweiger V., Werbiner D., Brumer G., Tuschl R.J., Laessle R.G., Krieg J.C., Fichter M.M., Pirke K.M.: Circadian pattern of large neutral aminoacids, glucose, insulin and food intake in anorexia nervosa and bulimia nervosa. Metabolism 40, 503-507, 1991.
43. Knopf R.F., Conn J.W., Fajans S.S., Floyd J.C., Guntsche E.M., Ruil J.A.: Plasma growth hormone response to intravenous administration of amino acids. J. Clin. Endocrinol. Metab., 25, 1140-1144, 1965.
44. Merimee T.J., Rabinowitz D., Fineberg S.E.: Arginine-initiated release of human growth hormone. N. Engl. J. Med., 26, 1434-1439, 1969.
45. Kuhara T., Ikeda S., Ohned A., Sasaki Y.: Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am. J. Physiol., 260, E21-E26, 1991.
46. Suematsu D., Ishikawa H., Kuboki T., Ito T.: Statistical studies on anorexia nervosa in Japan: detailed clinical data on 1011 patients. Psycother. Psychosom., 43, 96-103, 1985.
47. Sodeman, Sodeman: Pathologic physiology. Mechanism of disease. Philadelphia, W.B. Saunders Company, 1974, pp. 846-863.
48. Podolsky S., Sivaprasad R.: Assessment of growth hormone reserve: comparison of intravenous arginine and subcutaneus glucagone stimulation test. J. Clin. Endocrinol. Metab., 35, 580-584, 1972.
49. Casper R.C., Davis J.M., Padney G.N.: The effect of the nutritional status and weight changes on hypothalamic functional tests in anorexia nervosa. In: Vigersky R. (Ed.), Anorexia Nervosa. New York, Raven Press, 1977, pp. 137-147.
50. Brambilla F., Ferrari E., Cavagnini F., Invitti C., Zanoboni A., Massironi R., Catalano M., Cocchi D., Müller E.E.: Alpha 2-adrenore-ceptor sensitivity in anorexia nervosa: growth hormone response to Clonidine or growth hormone releasing hormone stimulation. Biol. Psychiatry, 25, 256-264, 1989.
51. Sizonenko P.C., Rabinovitch A., Schneider P., Paunier L., Wollheim C.B., Zahnd G.: Plasma growth hormone, insulin and glucagone responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth deficiency, panhypopituitarism and anorexia nervosa. Pediatr. Res., 9, 733-738, 1975.
52. Hoffman D.M., Nguyen T.V., O'Sullivan A.J., Baxter R.C., Ho K.K.: ITT and IGF-I in the diagnosis of growth hormone deficiency in adults. Lancet 27, 613-614, 1994.
53. Frankel R.J., Jenkins J.S.: Hypothalamic pituitary function in anorexia nervosa. Acta Endocrinol. (Copenh), 78, 209-213, 1975.
54. Blicke J.F., Reville P., Stephan F., Meyer P., Démangeât C, Sapin R.: The role of insulin, glucagone and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa. Horm. Metab. Res., 16, 336-340, 1984.
55. Naka Y., Koh T., Kimoshita F.: The prolactin, growth hormone and Cortisol response to insulin-induced hypoglycemia in anorexia nervosa. Int. J. Eating Disord., 6, 357-362, 1987.
56. Brauman H., Grégoire F.: The growth hormone response to insulin induced hypogly-caemia in anorexia nervosa and control underweight subjects. Eur. J. Clin. Invest., 5, 289-295, 1975.
57. Casper R.C., Pandey G., Jaspan J.B., Rubenstein A.H.: Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year follow-up compared to control subjects. Psychiatry Res., 25, 283-299, 1988.
58. Tamai H.T., Kiyohara K., Mukuta T., Kobayashi N., Komaki G., Nakagawa T., Kumagai L.F., Aoki T.T.: Responses of growth hormone and Cortisol to intravenous glucose loading test in patients with anorexia nervosa. Metabolism, 40, 31-34, 1991.
59. Mercado M., Baumann G.: Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. Arch. Med. Res., 26, 101-109, 1995.
60. Maeda K., Kato Y., Yamaguchi N.: Growth hormone release following thyrotropin-releasing hormone injection into patients with anorexia nervosa. Acta Endocrinol., 81, 1-8, 1976.
61. Maeda K., Tanimoto K., Chihara K.: Abnormal growth hormone release following luteinizing hormone releasing hormone in anorexia nervosa. Jpn. J. Psych. Neurol., 41, 41-45, 1987.
62. Kiriike N., Nishiwaki S., Izumiya Y., Maeda K., Kawakita Y.: Thyrotropin, prolactin and growth hormone response to intravenous administration of aminoacids. J. Clin. Endocrinol. Metab., 22, 167-171, 1987.
63. Valcavi R., Zini M., Portioli I.: Triiodoty-ronine administration reduces serum growth hormone levels and growth responses to thyrotropin-releasing hormone in patients with anorexia nervosa. Psyconeuroendocrinology, 15, 287, 1990.
64. Rolla M., Andreoni A., Bellitti D., Ferdeghini M., Ghigo E., Müller E.E.: Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders. J. Endocrinol., 140, 327-332, 1994.
65. Masuda A., Shibasaki T., Hotta M., Suematsu K., Shizume K.: Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin C level in the abnormal GH secretion. J. Endocrinol. Invest., 11, 297-301, 1988.
66. Tamai H.T., Komaki G., Matsubayashi S., Kobayashi N., Mori K., Nakagawa T., Truong M.P., Walter R.M. Jr., Kumagai L.F.: Effect of cholinergic muscarinic receptor blockade on human growth factor (GH)-releasing hormone-(l-44)-induced- GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 70, 738-741, 1990.
67. Rolla M., Andreoni A., Belliti D., Cristofani R., Federghini M., Muller E.E.: Blockade of cholinergic muscarinic receptors by pyren-zepine and GHRH-induced GH secretion in the acute recovery phase of anorexia nervosa and atypical eating disorders. Biol. Psychiatry, 29, 1079-1086, 1991.
68. Gianotti L., Arvat E., Valette M.R., Ramunni J., Di Vito L., Maccagno B., Camanni F., Ghigo E.: Effects of beta-adrenergic agonists and antagonists on the GH response to GHRH in anorexia nervosa. Biol. Psychiatry 43, 181-187, 1998.
69. Gianotti L., Fassino S., Abbate Daga G., Lanfranco F., De Bacco C, Ramunni J., Arvat E., Maccario M., Ghigo E.: Effects of free fatty acids and acipimox, a lypolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. Clin. Endocrinol., 52, 713-720, 2000.
70. Ghigo E., Arvat E., Gianotti L., Nicolosi M., Valetto M.R., Avagnina S., Bellitti D., Rolla M., Müller E.E., Camanni F.: Arginine but not pyridostigmine, a Cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol. Psychiatry, 36, 689-695, 1994.
71. Rolla M., Andreoni A., Belliti D., Ferdeghini M., Ferrannini E.: Failure of glucose to suppress GH response to GHRH in patients with anorexia nervosa. Biol. Psychiatry, 27, 215-222, 1990.
72. Gianotti L., Rolla M., Arvat E., Belliti D., Valetto M.R., Ferdeghini M., Ghigo E., Müller E.E.: Effect of somatostatin infusion on the somatotrope responsiviness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol. Psychiatry, 43, 334-349, 1999.
73. Angelin B., Rudling M.: Growth hormone and hepatic lipoprotein metabolism. Curr. Opin. Lipidol., 5, 160-165, 1994.
74. Marcus C, Margery V., Kamel A., Bron-negard M.: Effects of growth hormone on lipolysis in humans. Acta Pediatr., 406, 54-59, 1994.
75. Ghigo E., Arvat E., Broglio F., Giordano R., Gianotti L., Muccioli G., Papotti M., Graziani A., Bisi G., Deghenghi R., Camanni F.: Endocrine and non-endocrine activities of growth hormone segretagogues in humans. Horm. Res., (suppl 3), 9-15, 1999.
76. Bowers C.Y.: Unnatural growth hormone-releasing peptide begets natural Ghrelin. J. Clin. Endocrinol. Metab., 86, 1464-1469, 2001.
77. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Nijima A., Fujino M.A., Kasuga M.: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology, 120, 337-345, 2001.
78. Nagaya N., Kojima M., Uematsu M., Yama-gishi M., Hosoda H., Oya H., Hayashi Y., Kangawa K.: Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1483-R1487, 2001.
79. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S.: A role for ghrelin in the central regulation of feeding. Nature, 409, 194-198, 2001.
80. Tschop M., Weyer C, Tatarrani P.A., Devanarayan V., Ravussin E., Heiman M.L.: Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709, 2001.
81. Giusti M., Foppiani L., Ponzani P., Cuttica CM, Falivene M.R., Valenti S.: Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. J. Endocrinol. Invest., 20, 257-263, 1997.
82. Popovic V., Micic D., Damjanovic S., Obradovic S., Djurovic M., Petakov M., Grudic D., Golubicic I., Nikitovic M., Mitrovic N., Dieguez C., Casanueva F.F.: Growth hormone segretagogues in pathological states: diagnostic implications. Acta Paediatr. (Suppl.), 423, 97-101, 1997.
83. Shintani M., Ogawa J., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K.: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic that antagonizes leptin action through the activation of hypothalamic neurone Y/Yl receptor pathway. Diabetes, 50, 227-232, 2001.
84. Argenté J., Caballo N., Barrios V., Munoz M.T., Pozo J., Chowen J.A., Hernandez M.: Disturbances in the growth hormone-insulin like growth factor axis in children and adolecents with different eating disorders. Horm. Res., 48 (Suppl 4), 16-18, 1997.
85. Müller E.E., Rolla M., Ghigo E., Belliti D., Arvat E., Andreoni A., Torsello A., Locatelli V., Camanni F.: Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophy-siological, diagnostic and therapeutic implications. Drugs, 50, 805-837, 1995.
86. Gerner R.H., Yamada T.: Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res., 238, 298-302, 1982.
87. Kaye W.H., Rubinow D., Gwirtsman H.E., George D.T., Jimerson D.C., Gold P.W.: CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic-pituitary-adrenal cortical axis. Psychoneuro-endocrinology, 13, 265-272, 1988.
88. Arce V.M., Cella S.G., Locatelli V., Müller E.E.: Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin releasing hormone. Neuroendocrinology, 53, 467-472, 1991.
89. Thomas-G.B., Cumminis J.T., Francis H., Sudbury A.W., Mc Cloud P.I., Clarke I.J.: Effect of restricted feeding on the relationship between hypophyseal portal concentrations of growth hormone (GH)-releasing factor and somatostatin and jugular concentrations of GH in ovariectomized ewes. Endocrinology, 128, 1151-1158, 1991.
90. De Marinis L., Mancini A., Valle D., Bianchi A., Gentilella R., Milardi D., Mascadri C., Giustina A.: Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. Metabolism, 49, 155-159, 2000.
91. Tannenbaum G.S., Painson J.C., Lengyel A.M., Brazeau P.: Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Endocrinology, 124, 1380-1388, 1989.
92. Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F.: Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab., 59, 1025-1026, 1984.
93. Stoving R.K., Hangaard J., Habsen-Nord M., Hagen C: A review of endocrine changes in anorexia nervosa. J. Pediatr. Res., 33, 139-152, 1999.
94. rd Annual Meeting of the American Psychiatric Association, San Francisco, 1980.
95. Bellone J., Ghigo E., Procopio M., Arvat E., Valente F., Boffano GM, Maccario M., Dentelli P., Camanni F.: Comparison of the potentiating effect of pyridostigmine, argi-nine and propanolol on the GHRH induced GH release in short children. Panminerva Med., 35, 1-4, 1993.
96. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., Ma Z., Vignati L., Bowsher R., Herzog D., Klibanski A.: Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 81, 3861-3863, 1996.
97. Eckert E.D., Pomeroy C, Raymond N., Kohier P.F., Thuras P., Bowers C.Y.: Leptin in anorexia nervosa. J. Clin. Endocrinol. Metab., 83, 791-795, 1998.
98. Haluzik M., Papezova M., Nedvidkova J., Kabrt J.: Serum leptin levels in patients with anorexia nervosa before and after partial refeeding: relationships to serum lipids and biochemical nutritional parameters. Physiol. Res., 48, 197-202, 1999.
99. Pombo M., Pombo CM, Astorga R., Cordido F., Popovic V., Garcia-Mayor R.V., Dieguez C., Casanueva F.F.: Regulation of growth hormone secretion by signals produced by the adipose tissue. J. Endocrinol. Invest, 22, 22-26, 1999.
100. Friedman J.M., Halaas J.L.: Leptin and the regulation of body weight in animals. Nature 395, 763-770, 1998.
101. Schwartz M.W., Woods S.C., Porte D.J., Seeley R.J., Bskin D.J.: Central nervous system control of food intake. Nature, 404, 661-671, 2000.
102. Delvenne V., Goldman S., De Maertelaer V., Simon Y., Luxen A., Lotsra F.: Brain hypo-metabolism of glucose in anorexia nervosa: normalization after weight gain. Biol. Psychiatry, 40, 761-768, 1996.
103. Delvenne V., Goldman S., De Maertelaer V., Lotsra F.: Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int. J. Eating Disord., 25, 29-37, 1999.
104. Ho KY., Veldhuis JD, Johnson ML, Furlanetto R.: Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Invest. 198, 968-975.
105. Herington A.C.: Growth hormone receptor and binding protein: distribution and function. J. Pediatr. Endocrinol. 6, 235-240, 1993.
106. Strobl J.S., Thomas M.J.: Human growth hormone: Pharmacol. Rev., 46, 1-34, 1994.
107. Hochberg Z., Hertz P., Colin V., Ish-Shalom S., Yeshurun D., Youdim MB, Amit T.: The distal axis of growth hormone (GH) in nutritional disorders: GH binding protein, insulin-like growth factor-I (IGF 1), and IGF-1 receptors in obesity and anorexia nervosa. Metabolism, 41, 106-112, 1992.
108. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., Hintz R.L.: Somatomedin C effects on both the hypothalamus and the pituitary. Science, 212, 1279-1288, 1981.
109. Ceda G.P.: IGFs in the feedback control of GH secretion: hypothalamic and/or pituitary action? J. Endocrinol. Invest., 18, 734-737, 1995.
110. Sato M., Frohman L.A.: Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology, 133, 793-799, 1993.
111. Sjögren K., Liu J., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Törnell J., Isaksson O.G.P., Jansson J.O., Ohlsson C.: Liver-derived insulin-like growth factor I (IGF I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA, 96, 7088-7092, 1999.
112. th Annual Meeting of the Endocrine Society, Minneapolis, June 11-14, 1997.
113. Uderwood L.E., Clemmons D.R., Maes M., D'Ercole A.J., Keteslegers J.M.: Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm. Res., 24, 166-176, 1986.
114. Conover CA., Lee P.D.K., Kanaley J.A., Clarkson J.T., Jensen M.D.: Insulin regulation of insulin-like growth factor binding protein-1 in obese and non obese humans. J. Clin. Endocrinol. Metab., 74: 1355-1360, 1992.
115. Melmed S.: Insulin suppresses growth hormone secretion by rat pituitary cells. J. Clin. Invest. 73, 1425-1433, 1984.
116. Yamashita S., Melmed S.: Insulin regulation of rat growth hormone gene transcription. J. Clin. Invest. 78, 1008-1014, 1986.
117. Fukuda I., Hotta M., Hizuka N., Takano K., Ishikawa Y., Asakawa-Yasumoto K., Tagami E., Demura H.: Decreased serum levels of acid-labile subunit in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 84, 2034-2036, 1999.
118. Hotta M., Fukuda I., Sato K., Hizuka N., Shibasaki T., Takano K.: The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 200-206, 2000.
119. Scanlon M.F., Issa B.G., Dieguez C: Regulation of growth hormone secretion. Neuroendocrinology, 46, 149-154, 1996.
120. Nagakawa K., Matsubara M., Obara T., Kubo M., Akikawa K.: Responses of pituitary and adrenal medulla to insulin-induced hypoglycaemia in patients with anorexia nervosa. Endocrinol. Jpn., 32, 719-724, 1985.
121. Assaad S.N., Cunningham G.R., Samaan N.A.: Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease. Metabolism 39, 349-356, 1990.
122. Favaro A., Caregaro L., Burlina AB, Santonastaso P.: Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosom. Med., 2000. 62, 535-538.
123. Alvarez C.V., Mallo F., Burguera B., Cacicedo L., Dieguez C., Casanueva F.F.: Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone response to growth hormone-releasing hormone in the rat. Neuroendocrinology, 53, 185-189, 1991.
124. Steppan CM., Bailey S.T., Bhat S., Brown EJ, Banerjee R.R., Wright CM, Patel H.R.; Ahima R.S., Lazar M.A.: The hormone resistin links obesity to diabetes. Nature, 18, 292-293, 2001.